Codex @codex  0

Antibody affinity concerns one paratope binding one epitope. A Fab fragment supplies a single-site comparison. ^[ref] In the dilute chemical equilibrium model below, smaller dissociation constant $K_d$ means larger antibody equilibrium occupancy at the same free antigen concentration. State the antigen, temperature and buffer solution: a dissociation constant is not a context-free score. It does not alone specify how fast attachment or detachment occurs.

Antibody equilibrium occupancy counts occupied antibody binding sites, rather than retained assay label. For an original 1:1 model, let $A$ denote an unoccupied site, $E$ free antigen bearing one accessible epitope, and $AE$ their complex. At chemical equilibrium, writeSquare brackets mean concentrations. The dissociation constant $K_d$ here has concentration units. This is the same independent-site calculation as receptor binding occupancy, now applied to an antibody binding site. The last equality follows by substituting $[AE]=[A]c/K_d$ into the occupied fraction and cancelling $[A]$.

Assume identical independent sites, reversible 1:1 binding, dilute chemical solution behavior, fixed temperature and buffer solution, and enough time for chemical equilibrium. Exclude two-arm bridging, cross-reactivity and inaccessible sites from this model. Crucially, $c$ is free antigen concentration; substituting the amount supplied per volume requires negligible depletion by binding. Independent IgG arms could obey this model site by site, but it does not describe avidity from bridging a surface.

Stipulate $K_d=20\mathrm{nM}$, with $1\mathrm{nM}=10^{-9}\mathrm{mol}{\mathrm{L}}^{-1}$. Free antigen concentrations $2$, $20$ and $200\mathrm{nM}$ give $\theta =1/11$, $1/2$ and $10/11$. A second stipulated dissociation constant of $200\mathrm{nM}$ instead gives $\theta =1/11$ at $c=20\mathrm{nM}$. Both curves approach one at large $c$: a nearly saturated readout can conceal an antibody affinity difference. These are invented values, with no universal threshold for a useful antibody.

A Western blot readout additionally depends on Western blot transfer, accessible epitopes, loss during washing and Western blot antibody detection. Western blot response saturation can flatten the final signal even when binding itself remains responsive. An ELISA also reports retained label through an enzyme readout, rather than automatically reporting $\theta$. Thus half of an assay's maximum signal need not occur at $c=K_d$. Varying free antigen through concentrations near the candidate dissociation constant, while checking depletion and the readout's response, is more informative than comparing a single saturated point.

A concrete comparison used a Biacore T100 with a CM5 chip bearing the target receptor; unused reactive surface groups were blocked. At $25{}^{\circ }\mathrm{C}$ in a pH 7.4 buffer solution, intact IgG and its Fab fragment were injected for $180\mathrm{s}$ at $5\mu \mathrm{L}/\min$; dissociation was monitored for $3600\mathrm{s}$. The optical response tracks changes in refractive index near the surface, rather than counting occupied paratopes directly. A reference surface and blank injections corrected background; association and dissociation responses were fitted with a 1:1 model. The reported intact-IgG detachment was slower than that of the Fab fragment. ^[ref]

This comparison supports format-dependent attachment, not an intrinsic single-site antibody affinity for intact IgG. The reference and blanks address background, not two-arm avidity, surface accessibility or delivery by diffusion. The paper's fitted 1:1 constants alone cannot distinguish those mechanisms. Its Fab fragment comparison therefore motivates specifying the binding format before interpreting a dissociation constant; a good fit does not establish a unique molecular model.

Avidity is the combined strength of multivalent attachment. An intact IgG can make two contacts when accessible epitopes have suitable spacing. ^[ref] If one contact breaks while the other remains, the detached arm stays nearby and can bind again before the whole antibody escapes. That geometric advantage does not require changing either paratope's intrinsic antibody affinity. Two arms binding two separate freely moving antigens do not automatically provide the same tethering advantage. Epitope spacing, accessibility and surface density matter; avidity is not obtained by adding two dissociation constants.

The equilibrium strength of association under specified conditions. For simple one-to-one ligand binding, a smaller dissociation constant corresponds to stronger affinity; a predicted bound pose does not itself determine this constant.

An enzyme is a biological catalyst: it accelerates a chemical reaction and is regenerated after a successful catalytic cycle. Most enzymes are proteins, but catalytic RNA molecules, called ribozymes, also exist. Many reactions needed by a biological cell would proceed too slowly under its ordinary conditions without enzymes. See Cooper, The Cell: the central role of enzymes as biological catalysts.

The biological beauty is selective speed. A biological cell contains many possible reactants; its enzymes help determine which transformations happen on a useful timescale. In metabolism, one step's reaction product can become another step's substrate, so selective catalysts support an organized flow of material.

The ribosome is a striking biological example: the machinery that builds proteins has RNA at its catalytic centre. The complete ribosome contains both RNA and proteins, but its bond-forming active site is built from RNA. Structural evidence established this distinction in Nissen et al., The structural basis of ribosome activity in peptide bond synthesis, Science 289, 920–930 (2000).

Selection occurs at an active site, the region where substrate binding and catalytic chemistry take place. Shape and chemical interactions favour some substrates over others; binding can also reshape the enzyme, an induced fit. Recognition alone is insufficient: holding a substrate extremely tightly need not make it react quickly. Catalysis requires a favourable route through the transition state, the high-barrier configuration between reactants and reaction products. Positioning reactive groups and stabilizing this configuration relative to the bound substrate can lower that barrier. Specificity is often strong, but need not mean exactly one acceptable substrate. See Cooper, The Cell: mechanisms of enzymatic catalysis.

Read the diagram numerically. Its chosen Gibbs free energies are $0$ for the reactants and $-10\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ for the reaction products. The uncatalysed peak is $60\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$, whereas the catalysed peak is $40\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. The forward free-energy barriers are therefore $60$ and $40\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$; viewed from the reaction products, the reverse barriers are $70$ and $50\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. Both decrease by $20\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$, while the endpoint difference stays $-10\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$. These are constructed values, not measurements of a particular enzyme.

This separates chemical kinetics from chemical equilibrium. An enzyme changes how rapidly the system approaches chemical equilibrium; it does not change the equilibrium constant for the same overall chemical reaction under the same conditions. Faster catalysis therefore supplies no extra driving energy. In a biological cell, continuing supply of reactants and removal of reaction products can nevertheless sustain a net flow: the surroundings keep that system away from chemical equilibrium. See IUBMB, Symbolism and terminology in enzyme kinetics: basic definitions.

Some enzymes require a cofactor, an additional nonprotein component such as a metal ion or a small organic molecule. Organic helpers are often called coenzymes; they can assist transfers that the protein alone cannot readily perform. The cofactor may remain bound or exchange with the surroundings, depending on the system. A coenzyme can be chemically changed in one reaction and regenerated by another: regeneration of the enzyme does not mean every helper is unchanged in that individual reaction. Some enzymes need no additional cofactor. See Alberts et al., Molecular Biology of the Cell: small molecules associated with proteins and Alberts et al., activated carriers and their regeneration.

How much faster does adding substrate make a reaction? Enzyme kinetics gives a quantitative answer when a model's assumptions fit. For an illustrative reaction obeying Michaelis-Menten kinetics, use the Michaelis-Menten equation with substrate concentration $s$, limiting reaction rate $V_{\max }$ and Michaelis constant $K_M$. At $s/K_M=0.1$, substitution gives $v/V_{\max }=0.1/1.1=1/11\approx 0.0909$. At $s/K_M=1$, it gives $1/2$; at $s/K_M=10$, it gives $10/11\approx 0.9091$. Thus a hundredfold increase in substrate between the first and last examples yields only a tenfold increase in reaction rate.

For a chosen $V_{\max }=110\mu \mathrm{M}\mathrm{mi}{\mathrm{n}}^{-1}$, those fractions mean reaction rates of $10$, $55$ and $100\mu \mathrm{M}\mathrm{mi}{\mathrm{n}}^{-1}$. Doubling substrate from $10K_M$ to $20K_M$ raises the normalized rate only from $10/11$ to $20/21\approx 0.9524$, a relative increase of about $4.76\%$. In this simplest model, the catalytic machinery is already nearly fully occupied. Doubling the amount of active enzyme instead doubles $V_{\max }$ and the predicted reaction rates at fixed free substrate concentration, provided the other conditions are unchanged. This distinction helps decide whether additional substrate or additional catalytic capacity could improve throughput.

The interpretation has limits. The simplest Michaelis-Menten kinetics assumes a single substrate, fixed active enzyme amount, a suitable quasi-steady-state approximation, and initial measurements with negligible reverse reaction from accumulated reaction product. Substantial depletion, interacting binding sites, or inhibition by excess substrate can invalidate this model. Within it, $K_M$ is the substrate concentration giving half the limiting reaction rate; it is not generally the binding dissociation constant $K_d$. See IUBMB, enzyme kinetics: steady-state approximation and substrate dissociation and IUBMB, Michaelis-Menten and non-Michaelis-Menten kinetics. Measuring activity also requires specified temperature, pH and necessary cofactor availability: a weak signal can reflect unsuitable conditions rather than little enzyme. See Brooks et al., Assay Guidance Manual: basics of enzymatic assays for HTS.

The positive concentration giving half of the maximal response in a Hill equation. This effective threshold need not equal an individual binding site's microscopic dissociation constant.

An empirical occupancy relation, with half-occupancy concentration $K_{1/2}$ and Hill coefficient $n$. A fitted $K_{1/2}$ need not be an individual site's microscopic dissociation constant.

An inhibition constant sets an inhibitor concentration scale in an enzyme kinetics model. In the rapid-binding construction under reversible enzyme inhibition, $K_i=[E]I/[EI]$ and $K_i^{\prime }=[ES]I/[ESI]$ are dissociation constants. Smaller values favour the corresponding bound population at fixed free inhibitor concentration. More generally, fitted inhibition constants need not be true binding dissociation constants; a mechanism must justify that interpretation.^[ref]

For example, choosing $I=K_i$ makes $[EI]=[E]$ in this model, but does not imply that half of all enzyme is $EI$: $ES$ and $ESI$ also contribute to the total population.

The substrate concentration giving half the limiting reaction rate in the Michaelis-Menten equation. In the elementary mechanism $E+S\rightleftharpoons ES\to E+P$, it is $K_M=(k_{-1}+k_{\mathrm{cat}})/k_1$ under the quasi-steady-state approximation, whereas the binding dissociation constant is $K_d=k_{-1}/k_1$.

For the Hanes-Woolf plot, the slope is $1/V_{\max }$, the vertical intercept is $K_m/V_{\max }$, and the horizontal intercept is $-K_m$. The lines have approximately equal slopes, $0.50\min \mu {\mathrm{M}}^{-1}$. The dashed TEM-1 line intercepts the vertical axis at about $13\min$, while the dotted TEM-52 line intercepts it at about $2.5\min$. ThusThe negative-axis intercepts independently give approximately $-26$ and $-5\mu \mathrm{M}$. Allow normal graph-reading uncertainty, especially at the smaller intercept. The limiting rates are similar; the Michaelis constant is substantially lower for TEM-52. A Michaelis constant is not generally a binding dissociation constant, and calculating a turnover number additionally requires the concentration of active enzyme.

weak biomolecular binding is useful because it makes molecular recognition reversible, responsive to concentration and compatible with rapid exchange. Here “weak” describes a relatively high dissociation constant for an individual biomolecular contact, not the fundamental weak force. For a simple reversible association $A+B\rightleftharpoons AB$,Here $k_{\mathrm{on}}$ is the association rate constant and $k_{\mathrm{off}}$ is the dissociation rate constant. The bound fraction assumes free $B$ is known and binding sites are equivalent and independent; the lifetime assumes a single exponentially dissociating state without rebinding. A contact with $K_d=10\mu \mathrm{M}$ is half occupied at a free partner concentration of $10\mu \mathrm{M}$, but only about 1% occupied at $0.1\mu \mathrm{M}$. Recruiting the partners to a cell membrane or scaffold can therefore turn binding on locally without changing their chemistry. Importantly, the same $K_d$ can result from different on- and off-rates: weak equilibrium binding does not by itself prove rapid dissociation.

This responsiveness supports signalling. Short recognition motifs in disordered regions can bind adaptor domains with modest affinity. A phosphorylation event can create a docking motif; subsequent dephosphorylation removes it. Partners can then exchange rather than remain permanently trapped in one complex. Several individually selective contacts allow the same protein to be recruited in different combinations and at different times. Sequence-specific hydrogen bonding, electrostatic complementarity and shape recognition still discriminate between partners, even when total binding free energy is modest. Conversely, nonspecific contacts can be useful during a search: reversible association with DNA confines a DNA-binding protein near possible targets, provided escape is fast enough to avoid sequestration on incorrect sites.

Weak contacts also solve turnover problems. An enzyme must stabilize a productive substrate arrangement and the transition state, yet release its product. Excessively tight ground-state or product binding can slow the overall cycle. A chaperone must capture exposed hydrophobic surfaces but subsequently release a client for folding or transfer. Thus maximal affinity is generally not the design objective; relative affinities and switching kinetics must match the sequence of tasks. Energy-consuming cycles can bias capture and release, while each individual binding step remains reversible.

Several weak contacts can collectively give strong, selective attachment through avidity. Once the first contact forms, tethering presents a second partner at an effective local concentration $C_{\mathrm{eff}}$. In a simple two-contact model, the relative statistical weight of the doubly bound state contains a factor $C_{\mathrm{eff}}/K_{d,2}$. Geometry, linker flexibility and accessibility determine this factor, so affinities cannot simply be added. Breaking one contact need not release the whole assembly; rapid local rebinding can stabilize an otherwise short-lived complex. Yet removing a modification or changing geometry can disassemble it. This is useful for a reversible scaffold, cell attachment or recognition of a particular pattern of modifications.

The yeast inhibitor Sic1 gives a particularly instructive example of weak recognition creating a regulatory threshold. Multiple phosphodegrons contribute to recognition by Cdc4, the substrate receptor of a ubiquitin ligase. Accumulation of phosphorylation can make degradation strongly responsive to cyclin-dependent kinase activity, whereas replacing the distributed weak recognition system by an overly strong motif can compromise appropriate timing.^[ref] The benefit is therefore a controlled decision, not merely stronger binding after adding more sites. The mechanism also illustrates why affinity measurements on one isolated peptide need not predict full-length substrate behaviour.

Multivalent weak interactions can additionally produce a collective assembly transition. Experiments with nephrin, the adaptor Nck and N-WASP showed concentration- and valency-dependent assembly coupled to actin regulation.^[ref] biomolecular phase separation can locally concentrate reaction partners while allowing exchange with the surroundings. However, visible droplets or fluorescence recovery alone do not establish that a cellular structure is a functional liquid phase. Reconstitution should vary concentration and valency, measure partitioning and reversibility, and include binding-defective mutants. Cellular tests must establish the relevant endogenous concentrations and show that disrupting the proposed contacts changes function without simply destroying the protein.

Experimentally, isothermal titration calorimetry can estimate binding thermodynamics, while surface plasmon resonance or solution kinetic measurements can resolve association and dissociation. For weak contacts, high concentrations make aggregation, nonspecific surface binding and ligand depletion important controls; a failure to retain a complex during purification is not proof that it never forms. Measurements in dilute solution should be compared with full-length partners, cell membranes or scaffolds where appropriate. Weak interactions provide adjustable, combinatorial recognition; localization, multivalency and regulated modification convert that flexibility into reliable biological behaviour.

Several concentrations reveal a sensitivity range and help distinguish resistance from a single-dose threshold effect. Increasing disc concentration increases the region in which diffusing drug exceeds the local growth-inhibitory concentration. The wild type has progressively larger clear zones, act1-117 has little or no detectable inhibition across the tested range, and act1-129 is inhibited much more strongly. The zero-drug disc provides a local control for the disc and vehicle; it is the fourth condition alongside the three nonzero concentrations.

A halo diameter is not directly proportional to a dissociation constant or a minimum inhibitory concentration: molecular diffusion, agar composition, uptake and growth rate contribute. Overlapping large halos can also limit comparison at high doses. Matched lawns, solvent exposure and incubation are necessary, and a quantitative growth assay in uniform drug concentrations would give a cleaner concentration–response curve. Multiple disc doses prevent a lack of inhibition at one weak dose from being mistaken for absolute resistance.

Complex composition requires identities, copy numbers and evidence that the components coexist in the same assembly. A list of nearby proteins is a useful starting point, but neither a direct protein-protein interaction nor a uniquely defined protein complex follows from that list. I would combine quantitative isolation, measurements in intact biological cells, and structural constraints, then repeat the measurements through a controlled perturbation time course.

An effective first experiment is affinity purification-mass spectrometry. Introduce an affinity tag at the endogenous gene encoding a candidate bait, verify normal subcellular localization and biological activity, isolate associated material under conditions preserving the assembly, and identify digested peptides by tandem mass spectrometry. Matching fragmentation spectra to a sequence database assigns candidate proteins; control the false discovery rate at both peptide and protein levels and retain evidence from sequence-unique peptides when related proteins share sequences. An endogenous tag reduces the risk that gene overexpression creates interactions through excessive concentration. An untagged sample, a tag-only or localization-matched control, and independent biological replicates distinguish specific enrichment from bead-binding and abundant contaminants. Quantitative controls help distinguish true interactions from background.^[ref]

Isolation has selective losses. A weak partner can dissociate during dilution or washing; a membrane protein assembly can be disrupted by its solubilizing agent. Compare extraction conditions, check recovery in the soluble and insoluble fractions, and use reciprocal co-immunoprecipitation from an independent subunit. Treatment with a nuclease tests whether the association depends on DNA or RNA, but removal after extraction can itself destabilize a real nucleic-acid-dependent assembly. Purification from mixed tagged and untagged cell populations, with distinguishable stable isotope labeling, can test whether partners exchange after cell disruption. A reciprocal enrichment supports coassociation; demonstrating a direct contact still requires additional evidence.

For stoichiometry, raw mass spectrometry intensity is insufficient because different peptides have different digestion and ionization efficiencies. Use calibrated peptide standards or carefully normalized quantitative estimates, ideally with several reference subunits. native mass spectrometry measures intact assembly masses and can distinguish candidate subunit counts, while controlled dissociation helps assign subcomplexes. Bound lipids, post-translational modifications, gas-phase losses and heterogeneous occupancy complicate assignment, so check the mass against the summed masses of candidate subunits. Size-exclusion chromatography coupled to multi-angle light scattering independently constrains assembly mass, although an unresolved mixture produces an average and the hydrodynamic size alone is not a molecular mass. Quantitative mass spectrometry of protein complexes can combine interaction strengths, abundance and stoichiometry.^[ref]

To avoid requiring a bait, fractionate native extracts by size-exclusion chromatography or another separation and quantify proteins in every fraction. Correlated elution profiles suggest membership of the same protein complex; comparison across an independent separation helps distinguish coincidence. This co-fractionation mass spectrometry can also reveal shifts from a large assembly into smaller forms after treatment. It may merge different assemblies sharing a subunit, and a failure to coelute does not exclude a transient interaction. chemical cross-linking mass spectrometry adds spatial information: identify pairs of linked residues, translate them into distance restraints appropriate to the reagent and residue accessibility, and ask whether a proposed assembly can satisfy them. A cross-link is a proximity constraint, not automatically a permanent interface; intermolecular assignment is especially difficult for identical subunits.

In living biological cells, proximity labeling captures an interaction neighbourhood before disruptive extraction. A bait fused to TurboID marks nearby proteins with biotin, allowing stringent enrichment and mass spectrometry. The original TurboID work demonstrated useful labeling over roughly ten minutes, which is much faster than older long-labeling implementations.^[ref] A localization-matched enzyme control, a no-added-biotin control and matched fusion abundance are essential. The labeling pulse integrates both spatial proximity and residence time; ten-minute labeling cannot resolve a seconds-long interaction sequence. Changes in ATP, biotin availability, enzyme activity or access to reactive residues can change the labeling signal independently of complex membership. A pulse followed by a chase does not make the covalent label disappear when the partner leaves.

Structural methods distinguish alternative interpretations of these measurements. cryo-electron microscopy can assign ordered subunits, estimate occupancy of resolved features, and separate some compositionally different particle classes. Flexible or small subunits may remain invisible despite being present. X-ray crystallography resolves stable interfaces but selects material that crystallizes. Förster resonance energy transfer between appropriately positioned labels tests nanometre-scale proximity in intact biological cells; single-particle tracking and fluorescence correlation spectroscopy can test comobility and exchange. Label placement, spectral cross-talk and accidental colocalization require controls. None of these techniques by itself reliably inventories every component.

The computational analysis should preserve these distinctions. Construct a protein interaction network with separate edge types for copurification, cross-linking and proximity labeling. Cluster reproducibly supported associations to propose modules, distinguish a stable core from variable accessory components, and integrate localization and measured protein abundance. Models such as AlphaFold 3 can propose interfaces for experimentally supported candidate components, but a confident predicted geometry does not demonstrate that an interaction occurs in the tested condition.^[ref] Test interfaces by site-directed mutagenesis, confirming normal protein folding, expression and localization before interpreting a lost interaction. Evaluate a proposed assembly against independently held-out cross-links or other measurements to reduce circular validation.

For perturbations, use vehicle controls, several doses and early-to-late sampling; randomize preparation and instrument order. Quantify input abundance alongside bait-normalized partner recovery. An illustrative relative recruitment statistic for partner $i$ at time $t$ iswhere $I^{\mathrm{IP}}$ is background-corrected recovered intensity, $b$ is the bait and $A_i$ is input abundance. This is an operational comparison under matched extraction and measurement response, not an absolute occupancy or dissociation constant. A doubled recovered partner signal with doubled input abundance and unchanged bait recovery gives $R_i=1$, illustrating why raw enrichment alone would mislead. Values near the detection limit need uncertainty bounds rather than unstable ratios.

A drug-induced loss of several core components could mean disassembly, degradation, changed localization or poor recovery. Distinguish them with input proteomics, microscopy and native fractionation, then test reversibility after washout and rescue by a drug-resistant target when feasible. For stress, monitor viability and extraction-resistant material; for disease-associated mutations, compare otherwise matched genetic backgrounds and rescue with the normal allele. post-translational modifications may recruit an accessory partner without changing the core. hydrogen-deuterium exchange mass spectrometry can then test interface exposure, but its altered exchange reports accessibility and structural dynamics rather than a new subunit by itself. A convincing remodeling claim is a reproducible change in assembly membership or occupancy, separated from changes in abundance, localization and assay recovery, and connected to a functional consequence.

Separate three causal steps: recognition of the modified RNA, occupancy of the target messenger RNA, and reduction of its degradation rate. Call the newly identified RNA-binding protein R. Its recovery in a screen need not mean it contacts the modified ribonucleotide directly; it could recognize a modification-dependent structure or arrive through another protein. Likewise, more target messenger RNA could reflect increased transcription rather than greater stability.

First reproduce the interaction using endogenous R and the endogenous target. Determine R's protein domains, expression and subcellular distribution, then use reciprocal RNA immunoprecipitation and crosslinking and immunoprecipitation to locate the occupied region. Normalize enrichment to input target abundance and R recovery, and include unrelated RNAs, a non-specific antibody and cells lacking R. Crosslink-based occupancy supports close contact, whereas recovery without crosslinking can preserve indirect complexes. Determine whether the relevant modification actually occurs near the binding site: mass spectrometry of purified target fragments can establish chemical identity, supplemented by a modification-specific mapping assay with known modified and unmodified standards. Bulk mass spectrometry of all cellular RNA cannot assign a modification to this particular transcript or position. Do not assume the modification is N6-methyladenosine merely because it is familiar.

Prepare short synthetic RNAs identical in nucleotide sequence, length, ends and labelling except for the single modified ribonucleotide. Measure binding of purified R over a concentration range by electrophoretic mobility shift assay or fluorescence anisotropy, with competition by unlabelled cognate and unrelated RNA. The dissociation constant distinguishes a quantitative preference from a binary pull-down impression. Verify that R is folded and sufficiently pure; include an RNA-binding-defective R mutant, several surrounding sequences and different modification positions. Modification-specific recovery from a cellular extract can disappear with purified R, revealing a missing partner rather than disproving the original screen.

Distinguish chemical recognition from structural recognition. Compare RNA secondary structure with and without the modification by RNA structure probing. Then disrupt the stem without changing the binding motif, or restore pairing through compensatory mutations. If an unmodified but constitutively exposed motif binds R, and restoring occlusion suppresses binding even when the modification remains, an RNA modification switch is plausible. Direct recognition is supported when modification discrimination persists after accessibility is matched and is lost upon a specific R binding-pocket mutation. Structural work can identify the contacts, but binding and structure controls remain essential. Modification-dependent exposure of a binding motif has an experimental precedent in the N6-methyladenosine-dependent RNA modification switch for HNRNPC.^[ref]

Establish stability by acute depletion of R, followed by a metabolic RNA labelling pulse and chase. Measure loss of labelled target molecules using appropriate spike-ins and a time course spanning the expected half-life, while independently estimating newly synthesized target RNA. SLAM-seq is one possible implementation: chemical treatment makes incorporated 4-thiouridine detectable through characteristic sequencing changes.^[ref] Include unlabelled controls, check label toxicity and correct for label reutilization or incomplete chase. When reporting molecules per biological cell, separate dilution through increasing cell number from chemical degradation. A transcription inhibitor time course provides an orthogonal check, but broad inhibition itself can change decay. Under a constant first-order degradation model, labelled molecules obeyA shorter half-life after R depletion, reversed by normal R but not its RNA-binding-defective mutant, establishes the proposed effect. Allow a more complex fit if the exponential decay model is inconsistent with the measured time course. At steady state, abundance is synthesis rate divided by degradation rate, so abundance alone cannot identify which rate changed.

Use a controlled target reporter gene carrying the occupied region, then remove or mutate that region and measure reporter messenger RNA decay. Preserve polyadenylation, RNA splicing and coding potential where possible, and distinguish site loss from altered RNA secondary structure. Manipulate the relevant modification-producing enzyme acutely, rescuing with normal or catalytically inactive enzyme; verify target-site modification after the manipulation. Cross the two perturbations: if R stabilizes the target specifically through the modification, removing the modification should reduce R occupancy and eliminate or substantially weaken the extra effect of removing R. This epistasis supports a shared pathway, but floor effects or redundant sites can obscure it. A site-specific chemically modified reporter helps separate local recognition from the many indirect consequences of removing a global modification enzyme.

Identify the affected decay step using poly(A) tail measurements, cap-state assays and mapping of decay intermediates. Test whether R excludes a microRNA-loaded Argonaute complex or a decay-promoting RNA-binding protein, blocks an endonuclease, inhibits deadenylation or decapping, or recruits a protective partner such as poly(A)-binding protein. Use protein interaction analysis with and without ribonuclease to distinguish RNA-bridged association from a more direct interaction. R mutants that retain target binding but lose a partner interaction separate recruitment from recognition. Depleting the implicated decay factor should suppress the destabilization caused by R loss; purified-system decay assays can test whether R alone physically protects the substrate.

Measure biological translation and subcellular location in parallel, using ribosome profiling or a controlled biological translation reporter and single-molecule fluorescence in situ hybridization. R might stabilize the target indirectly by altering ribosome loading or compartment access. Inhibiting biological translation can itself alter decay, and colocalization in a granule does not establish protection. The reported stabilizing action of IGF2BP proteins on modified targets provides a candidate mechanism to compare with, rather than an identity to assign to R.^[ref] The strongest mechanism links a verified target-site modification to R binding, a defined protective activity and a rescued change in target half-life.

Yes: the binding data support strong positive cooperativity. On the linear concentration axis, occupancy rises sigmoidally, with reported Hill coefficient $n=3.97\pm 0.13$, far above the noncooperative value one. The Hill equation gives the useful empirical descriptionThe steep response is consistent with the independent evidence for a four-subunit assembly. The fitted half-occupancy concentration is not automatically the microscopic dissociation constant of one isolated site.

Binding alone does not demonstrate which conformational change is coupled to occupancy. Here the microscopy supplies the complementary structural evidence, so together the observations support a cooperative ligand-dependent switch. A Hill coefficient near four is consistent with strongly coupled binding in a tetramer, but is not an independent exact count of ligands.

The small binding RNA can serve conceptually as an RNA aptamer recognition probe. Coupling recognition to an optical label would make a specifically bound virus appear as a moving fluorescent spot. Single-particle tracking estimates successive spot positions and fits their displacement statistics. Specificity is assessed by comparison with a nonbinding recognition probe or a sample without the target, while the much faster diffusion of unbound probes distinguishes freely moving label from target-associated signal. Subnanomolar dissociation constant supports appreciable occupancy at low probe abundance, but affinity alone does not determine the dissociation lifetime because $K_d=k_{\mathrm{off}}/k_{\mathrm{on}}$. This describes detection principles, not an operational virus preparation or labelling protocol.

For a dilute spherical particle of radius $a=60\mathrm{nm}$ in bulk water, the Stokes–Einstein relation gives, at an explicitly assumed $T=300\mathrm{K}$,A $2\mathrm{nm}$ free probe would have $D\simeq 110\mu {\mathrm{m}}^2{\mathrm{s}}^{-1}$, roughly thirty times larger. The recognition probe changes the target's hydrodynamic size only modestly in this estimate.

For isotropic Brownian motion, the mean vector displacement is zero. In $t=0.1\mathrm{s}$, distinct measures of how far it moves areA two-dimensional image instead gives projected root-mean-square displacement $\sqrt{4Dt}=1.21\mu \mathrm{m}$ and mean projected distance $\sqrt{\pi Dt}=1.07\mu \mathrm{m}$. The projected mean squared displacement is $4D\Delta t$; independent localization errors of variance ${\sigma }^2$ in each coordinate add $4{\sigma }^2$. Finite exposure blurs motion, and nearby walls reduce diffusion; those effects must be separated from particle size when interpreting a trajectory.

His238 contributes strongly to turnover, with a plausible acid/base or electrostatic role near the attacking water. Replacing its imidazole by the methyl side chain of alanine removes both proton-transfer capacity and a positioned polar group, so the large fall in turnover number fits impaired chemical catalysis. A candidate role is acceptance of a proton from zinc-bound water, or stabilization and subsequent proton shuttling around the attacking oxygen.

Little change in the Michaelis constant suggests that the major kinetic defect is not a gross loss of substrate recognition, but $K_M$ is not generally a binding dissociation constant: $K_M=(k_{-1}+k_{\mathrm{cat}})/k_1$ for the elementary scheme. Nor does reduced $k_{\mathrm{cat}}$ uniquely prove that His238 is the initial general base. Purified-protein controls should check fold, zinc occupancy and active concentration. Importantly, primary mouse-enzyme experiments found that His238 mutants could still hydrate a substrate analogue, directly illustrating this mechanistic limitation.^[ref]

Receptor binding occupancy is the fraction of binding sites occupied by a ligand. Consider reversible, noncooperative binding at chemical equilibrium, with homogeneous independent sites: every site has the same binding properties, and binding at one site does not change binding at another. Let $L$ denote free ligand, $R$ an unoccupied receptor site and $RL$ the bound complex. In this dilute concentration model,Square brackets denote concentrations; $R_T$ is the total site concentration. Here the dissociation constant $K_d$ has concentration units. Use free ligand in excess so binding negligibly depletes it; only under that approximation may the supplied total ligand concentration substitute for $[L]$. See Analysis of Receptor–Ligand Interactions: equilibrium binding and saturation.

For an illustrative dissociation constant $K_d=10\mathrm{nM}$, where $1\mathrm{nM}=10^{-9}\mathrm{mol}{\mathrm{L}}^{-1}$, free ligand concentrations $1$, $10$ and $100\mathrm{nM}$ give $\theta =1/11\approx 0.091$, $\theta =1/2=0.5$ and $\theta =10/11\approx 0.909$, respectively. At $[L]=K_d$, exactly half the sites are occupied in this model. Raising $[L]$ tenfold from $10$ to $100\mathrm{nM}$ raises occupancy from $50\%$ to about $91\%$, rather than tenfold: the finite pool of sites causes saturation.

A short derivation uses the law of mass action: at chemical equilibrium, association balances dissociation, giving $[RL]=[L][R]/K_d$. Substitute this into $\theta =[RL]/([R]+[RL])$ and cancel $[R]$ to obtain the displayed formula. The limiting values follow directly: zero free ligand gives zero occupancy, and increasing $[L]$ far above $K_d$ drives occupancy toward one.

Receptor binding occupancy is not automatically the fraction of maximal response. Signal amplification, differing effects of bound ligands, and downstream saturation can change the relationship. Consequently, $[L]=K_d$ specifies half occupancy here; it does not universally specify either half-maximal or maximal cellular response. These numbers describe a toy binding model, not measured responses of every receptor. See Higham and Colquhoun, 2024: the affinity–efficacy problem.

A biochemical receptor is a protein that recognizes a signal and couples its detection to a biological effect. Its binding partner is a ligand; recognition depends on compatible shape and chemical interactions at a binding site within the protein structure. Specificity is selective recognition, not a guarantee that only one ligand can bind. Binding also need not activate the receptor: a competing ligand may occupy it while preventing activation by another ligand. See Alberts et al., Molecular Biology of the Cell, 4th edition: protein binding and specificity.

Compare a cell-surface receptor, accessible to an extracellular ligand, with an intracellular receptor, whose ligand must reach the interior. A cell-surface receptor can detect a hydrophilic ligand without transporting it through the cell membrane. In contrast, some membrane-permeable signals reach intracellular receptors that regulate gene expression. Location and downstream coupling are separate distinctions: an ionotropic receptor directly gates an ion channel, whereas a metabotropic receptor works through intracellular signal transduction. See Clark, Douglas and Choi, Biology 2e, 9.1: receptor locations and mechanisms.

Receptor binding occupancy quantifies recognition separately from response. A dissociation constant measures binding in a specified equilibrium model; it does not by itself predict the cellular effect. This separation is useful when comparing signals that bind equally well but produce different responses, or when interpreting a binding experiment alongside a functional measurement.